Dietary modifications including smaller meals and avoiding carbonated beverages are typically the most effective first-line strategies
For patients sourcing peptides outside a clinical setting, the alcohol question is the smaller of two problems
This article does not assert any trademark claim and is produced for editorial and consumer education purposes only
Moreover, prior trials have suggested potential safety concerns with GLP-1 receptor agonists in patients with heart failure with reduced ejection fraction (HFrEF), so the lack of any safety issues among patients with the lowest EFs in STEP-HFpEF also is certainly reassuring, Vaduganathan said
Cleveland Clinics Lou Ruvo Center for Brain Health by Nick Fewings 1.Huband N, Ferriter M, Nathan R, Jones H
Here, we review the physiology and pharmacology of GLP-1 agonists, their current clinical indications, nuanced perioperative considerations, and areas of research needed to establish the safest use of these agents for our patients